# Spatial domain identification method based on multi-view graph convolutional network and contrastive learning

**Authors:** Xikeng Liang, Shutong Xiao, Lu Ba, Yuhui Feng, Zhicheng Ma, Fatima Adilova, Jing Qi, Shuilin Jin

PMC · DOI: 10.1371/journal.pcbi.1013369 · PLOS Computational Biology · 2025-10-17

## TL;DR

This paper introduces a new deep-learning method for identifying spatial domains in tissues using graph convolutional networks and contrastive learning.

## Contribution

The novel DMGCN method combines multi-view graph convolutional networks with contrastive learning for improved spatial domain identification.

## Key findings

- DMGCN outperforms existing methods in spatial clustering and gene expression reconstruction.
- The method enhances accuracy and biological interpretability of spatial domain identification.
- Results are validated across multiple spatial transcriptomics datasets.

## Abstract

Spatial transcriptomics is a rapidly developing field of single-cell genomics that quantitatively measures gene expression while providing spatial information within tissues. A key challenge in spatial transcriptomics is identifying spatially structured domains, which involves analyzing transcriptomic data to find clusters of cells with similar expression patterns and their spatial distribution. To address these challenges, we propose a novel deep-learning method called DMGCN for domain identification. The process begins with preprocessing that constructs two types of graphs: a spatial graph based on Euclidean distance and a feature graph based on Cosine distance. These graphs represent spatial positions and gene expressions, respectively. The embeddings of both graphs are generated using a multi-view graph convolutional encoder with an attention mechanism, enabling separate and co-convolution of the graphs, as well as corrupted feature convolution for contrastive learning. Finally, a fully connected network (FCN) decoder is employed to generate domain labels and reconstruct gene expressions for downstream analysis. Experimental results demonstrate that DMGCN consistently outperforms state-of-the-art methods in various tasks, including spatial clustering, trajectory inference, and gene expression broadcasting.

Spatial transcriptomics technology not only provides high-resolution gene expression data but also completely preserves the spatial location information of each sequencing spot in tissue sections, offering an unprecedented multi-dimensional perspective for in-depth exploration of tissue heterogeneity and dissection of cellular microenvironments and functional partitions. Similar to the cell clustering task in single-cell data analysis, one of the core challenges in spatial transcriptomics data analysis is spatial domain identification—using algorithms to cluster sequencing spots with adjacent spatial locations and similar gene expression patterns into biologically meaningful functional regions. Although existing methods can achieve preliminary spatial domain partitioning, accurately capturing global semantic associations and balancing the modeling capabilities of local features and global structures remain critical scientific challenges when faced with non-linear gene expression patterns and spatial distribution relationships in complex tissues. Here, we propose a novel algorithmic framework that integrates multi-view graph convolutional networks and contrastive learning. Results across multiple datasets generated by different technologies demonstrate that our method significantly enhances the accuracy and biological interpretability of spatial domain identification.

## Full-text entities

- **Genes:** LINC00645 (long intergenic non-protein coding RNA 645) [NCBI Gene 100505967], REPS2 (RALBP1 associated Eps domain containing 2) [NCBI Gene 9185] {aka POB1}, CRISP3 (cysteine rich secretory protein 3) [NCBI Gene 10321] {aka Aeg2, CRISP-3, CRS3, SGP28, dJ442L6.3}, NUPR1 (nuclear protein 1, transcriptional regulator) [NCBI Gene 26471] {aka COM1, P8}, FCGR3B (Fc gamma receptor IIIb) [NCBI Gene 2215] {aka CD16, CD16-I, CD16b, FCG3, FCGR3, FCRIIIb}, VTCN1 (V-set domain containing T cell activation inhibitor 1) [NCBI Gene 79679] {aka B7-H4, B7H4, B7S1, B7X, B7h.5, PRO1291}, CPB1 (carboxypeptidase B1) [NCBI Gene 1360] {aka CPB, PASP, PCPB}, AQP3 (aquaporin 3 (Gill blood group)) [NCBI Gene 360] {aka AQP-3, GIL}, CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, SLITRK6 (SLIT and NTRK like family member 6) [NCBI Gene 84189] {aka DFNMYP}
- **Diseases:** Co-Convolution loss (MESH:D060085), MGCN (MESH:D015161), breast cancer (MESH:D001943), ZINB (MESH:D064726)
- **Chemicals:** DMGCN (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12533874/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12533874/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12533874/full.md

---
Source: https://tomesphere.com/paper/PMC12533874